https://www.selleckchem.com/pr....oducts/Tebipenem-piv
37% with other histologies were alive; p = 0.14. In 69% (n = 25), brachytherapy could be performed without acute complications. Aself-limiting bleeding occurred in 8% (n = 3), fever in 3% (n = 1), pneumothorax in 17% (n = 6), and pulmonary failure in 3% (n = 1). Patients with 20 Gy in 95% of planning target volume had higher pneumothorax rates needing intervention (31% vs. 5%, p = 0.04). Interstitial brachytherapy for pulmonary tumours is ahighly conformal therapy with minimal doses to the organs at risk. For the m
Like
Comment
Share
